• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

One-time charges force USDL loss

Article

Imaging services provider U.S. Diagnostic of West Palm Beach, FL, last week reported that one-time charges totaling $15.1 million were the cause of an $11.9 million net loss in the company's second quarter (end-June). USDL's loss was attributable in part

Imaging services provider U.S. Diagnostic of West Palm Beach, FL, last week reported that one-time charges totaling $15.1 million were the cause of an $11.9 million net loss in the company's second quarter (end-June).

USDL's loss was attributable in part to a $4.9 million charge to settle class-action lawsuits filed earlier this year relating to revelations about one of the company's mergers and acquisitions consultants (SCAN 8/6/97). Another charge was $2.8 million spent in the quarter on a settlement with former CEO Jeffrey Goffman, who left the company in the wake of the revelations. USDL also took a $3.7 million charge for asset-impairment losses related to goodwill, and another $3.7 million in professional fees related to the shareholders' suits and investigations of the company by NASDAQ and the Securities and Exchange Commission.

The good news for USDL came on the revenue side, with the company reporting sales of $57.5 million for the second quarter, compared with $15.6 million in the same period a year ago. USDL executives said that the quarter was a difficult one, but that it represented the end of the company's recent woes. USDL shareholders seemed to agree: On the NASDAQ exchange Friday, USDL shares closed at $8.06 a share, up over 3%, while the rest of the market tanked.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.